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Abstract
Background: There has been much recent interest in the quantification of visually evident heterogeneity within
functional grayscale medical images, such as those obtained via magnetic resonance or positron emission
tomography. In the case of images of cancerous tumors, variations in grayscale intensity imply variations in crucial
tumor biology. Despite these considerable clinical implications, there is as yet no standardized method for measuring
the heterogeneity observed via these imaging modalities.
Methods: In this work, we motivate and derive a statistical measure of image heterogeneity. This statistic measures
the distance-dependent average deviation from the smoothest intensity gradation feasible. We show how this
statistic may be used to automatically rank images of in vivo human tumors in order of increasing heterogeneity. We
test this method against the current practice of ranking images via expert visual inspection.
Results: We find that this statistic provides a means of heterogeneity quantification beyond that given by other
statistics traditionally used for the same purpose. We demonstrate the effect of tumor shape upon our ranking
method and find the method applicable to a wide variety of clinically relevant tumor images. We find that the
automated heterogeneity rankings agree very closely with those performed visually by experts.
Conclusions: These results indicate that our automated method may be used reliably to rank, in order of increasing
heterogeneity, tumor images whether or not object shape is considered to contribute to that heterogeneity.
Automated heterogeneity ranking yields objective results which are more consistent than visual rankings. Reducing
variability in image interpretation will enable more researchers to better study potential clinical implications of
observed tumor heterogeneity.
Background
There are hundreds of papers in the medical literature
about the importance of heterogeneity within various
types and degrees of cancerous tumors. In oncology
parlance, “tumor heterogeneity” generally means that a
whole tumor comprises distinct cellular sub-populations
[1]. These cell groups vary in morphology, histology and
growth rate, for example. The interactions of different
tumor cells with each other and with the microenviron-
ment are complex and not well understood [2]. In order
to understand intra-tumor biology, potentially subtle dif-
ferences near and within tumors must be quantified. The
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ultimate goal of tumor heterogeneity studies is to deter-
mine the implications and prognostic value of observed
variations in a host of clinically relevant tumor proper-
ties such as physical size, shape, cellular density, cellular
metabolism, hypoxia and vascularization. Each of these
biologically interesting properties generally are assayed
via an imaging modality—such as magnetic resonance
(MR), computed tomography (CT) or positron emis-
sion tomography (PET)—which outputs grayscale images.
Thus, the challenge of measuring biological heterogeneity
manifests as the quantification of visually evident intensity
variations in grayscale images.
Consider, for example, the PET image of a cancerous
tumor shown in Figure 1. Within the bulk of the tumor,
variation in the grayscale pixel intensities is seen. Toward
the bottom-left, a region of the brightest pixels is seen
to smoothly gradate to darker regions. Similar distinct
darker regions then are seen at the center and toward
© 2013 Brooks and Grigsby; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the
Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
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the top of the bulk, although neither follow an easily
described shape or pattern. Similarly amorphous bright
regions punctuate the periphery of the tumor bulk. It is
precisely these variations which interest the researchers
because variation in PET intensity implies variation in bio-
logical properties of the tumor. When one attempts to
perform a clinical study of those biological properties via
PET image data, two significant obstacles arise. First, the
variation in observed pixel intensity is difficult to describe
verbally [3]. As such, there is no convention for describing
the properties seen in tumor images. Thus, even experi-
enced clinicians are unlikely to describe the same tumor
in the same manner or, much less, even agree upon which
image features are salient. This complicates the devel-
opment of statistics used to quantify “obvious” intensity
variations. Second, the implementation of any statistic will
have to contend with relative paucities of pixel data. Con-
sider, for example, that a typical PET scanner renders a
4 × 4 × 5 mm3 physical region as a single pixel in the
final image [4]. If one assumes that a clinically typical
tumor volume of 40 cm3 is a sphere, then the largest cross-
sectional image contains only ≈90 tumor pixels. In fact, it
is common that oncology studies include a large fraction
of PET images where fewer than 20 pixels comprise the
entire tumor region. Therefore measuring the variation
within these small regions can be difficult since the use of
many statistics—including those common to texture anal-
ysis and correlation techniques [5]—requires large sample
sizes.
Several attempts to objectively quantify tumor hetero-
geneity have been published previously [6-10]. These
attempts largely have yielded mixed results. The more
rudimentary measures are non-spatial. That is, they
depend only upon the distribution of intensities, not the
spatial arrangement of those intensities within the tumor.
For example, although the standard deviation, skewness
and kurtosis clearly quantify variation of an intensity dis-
tribution, skewness and kurtosis have been shown not to
vary sufficiently to separate some cervical cancers into
groups of differing disease outcome [10]. Another non-
spatial measure of heterogeneity which was shown to
distinguish patient groups [6] was later demonstrated to
actually be a surrogate for tumor volume [10]. It has been
claimed that the image texture metrics introduced in the
seminal work of Haralick et al. [11] can be used as spa-
tial measures of heterogeneity [8,9]. However, many of
those more sophisticated metrics have been shown later
to be statistically irreproducible on tumor data [12]. In
general, even in cases where enough image data exists
to yield consistent inter-image comparison, it remains
unclear which texture metric corresponds to which sub-
jectively perceived image quality [11]. In short, there is no
standard for measuring tumor heterogeneity in a manner
consistent with expert visual inspection.
Figure 1 Variations in the grayscale intensity of this tumor are
evident. For example, contrast the bright region at the bottom-left to
the darker region in the center. The regions of varying intensity are
amorphous an diffusely bounded. In the present case, these regions
represent the heterogeneous uptake of a radio-labeled glucose
analogue (FDG). The vertical edge of this image corresponds to 64
mm. This image is also seen in Figure 4 as panel F1.
In this study, we develop and test a novel statistic which
may be used to quantify spatial variations in tumors
imaged in vivo which were identified and segmented via
independent analysis. In other words, we quantify the
spatial heterogeneity within definitively bounded objects
against a uniform background. Here, we do not seek to
attach any clinical or prognostic meaning whatsoever to a
given image or statistical value. Instead, we seek to give the
clinician a quantitative mechanism of declaring one image
to be x times more heterogeneous than another, such that
a set of similarly imaged objects may be ranked and com-
pared objectively. We compute our statistic on real PET
images of tumors exhibiting visually manifest variations in
size, shape and intra-tumoral intensity and find that our
numerical heterogeneity comparisons agree well with the
subjective comparisons made by experienced experts.
Methods
Motivation
Heterogeneity has application-specific connotation. Com-
mon to all applications, however, is that heterogeneity is
necessarily defined by the scale of interest. For example,
at scales much smaller than a single square, a chessboard
image could be interpreted as homogeneous. This is due
to the fact that at very small scales, neighboring pixels
are much more likely to be in the same square than they
are in one of differing color. At a scale on the same order
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of magnitude as the squares, the chessboard is more het-
erogenous because any pixel about one square size away
from an arbitrary pixel has approximately equal chance of
being either color. This is greater average variation than
in the previous case of usually being confined to a single
square. If the scale of interest becomes much larger than
the size of a single square, the image may again be con-
sidered homogeneous since, on average, anywhere in the
image, the pattern is precisely the same. When attempting
to quantify the heterogeneity in an image, one must make
clear the intended scale of interest.
Contrast the scale-dependence of heterogeneity to the
definitiveness of homogeneity. Ultimate homogeneity is
unambiguously defined as the state being the same at all
scales, e.g., an image of only a single color. We therefore
assume that heterogeneity may be clearly defined as dif-
ference from homogeneity. Of course, a perfectly homo-
geneous image contains no information and is therefore of
little practical use. The real images we study will contain
pixels of varying grayscale intensity. We thus seek to first
find the most homogeneous intensity transition between
given pixels with differing intensities. Consider two dis-
tinct image pixels where the grayscale intensity is I1 at
pixel one and I2 at pixel two. Assume that I1 > I2. Let r
be the distance measured from pixel one to an arbitrary
point along the straight line segment between pixels one
and two. The gradation between pixels one and two which
is as locally homogeneous as possible, for every distance r,
occurs when the whole intensity change is spread evenly
across the entire line, i.e, when the derivative dI/dr is
constant. We consider any deviation from that smoothest
possible transition to be heterogeneity.
Mathematical development
We are interested in measuring the variation within
grayscale image objects. We assume these objects have
already been identified and isolated via relevant standards.
We therefore begin with a definitively bounded object
against a uniform background of zero intensity. We take
as input a pair of distinct object pixels, which we arbitrar-
ily label as m and n. The mth pixel at image coordinate
(xm, ym) has a grayscale intensity Im. The nth pixel at image
coordinate (xn, yn) has a grayscale intensity In. The pair
separation distance rmn is simply the Euclidean distance
between the mth and nth pixel. The inter-pixel intensity
change is Imn = In − Im. The minimal discrete set of
pixels connecting the mth and nth pixels is taken to be
the Bresenham line [13] between those pixels, to which
we collectively refer as L. Thus, L is an ordered set of
pixels comprising the straightest line that can be drawn
from the mth pixel to the nth pixel while still being con-
strained to a discrete lattice of non-fractional pixels. The
smoothest possible gradation between these endpoints
occurs when In monotonically decreases (or increases) to
Im over L exhaustively. That is, when the intensity change
is spread evenly across the entire line connecting the end-
points. We compute the grayscale value yielding the most
homogeneous gradation
I(rml) = Im + In − Imrmn rml (1)
where rml is the Euclidean distance between themth pixel
and lth pixel in L. The absolute difference between the
homogenous grayscale value I(rml) and the actual value
at the lth pixel Il is computed for each pixel in L. These
differences are summed over L and then divided by the
discrete pair separation L, i.e., by the number of elements




|I(rml) − Il|, (2)
the average absolute intensity difference along a line con-
necting a pair of object pixels.
For each non-repeating pair of object pixels, we com-
pute the discrete distance L and I . The result is a pool
of values where any one value of L has associated with
it many values of I. Those multiple I values are then
ensemble-averaged for each L such that each discrete pair
separation possible then has associated with it only a
single value, I ≡ 〈I〉ens. The discrete distances are
normalized to the largest discrete distance (L˜) observed
amongst any object pixel pair. The I are then plotted
versus L/L˜.
The resulting plot may be interpreted as follows. In
essence, the plot measures how the average deviations
from homogeneity scale with percent object size. As that
percent distance approaches unity, the opportunity to
accrue larger deviations from homogeneity increases. The
simplest assumption is that object heterogeneity will then
accrue proportionally as more of the object is considered.
Thus, a curve observed to be well below the proportion-
ality line implies that progressively greater spans across
the object tend not to accumulate differences from a
smooth gradation. In other words, that object tends to
be more homogeneous. Conversely, an object with curve
well-above the proportionality line tends to be more het-
erogenous since deviations from smoothness accrue even
across smaller spans. One simple means of quantifying
the qualitative observation of a curve being above or
below the proportionality line is via the area under that
curve. We therefore define our heterogeneity quantifica-





Because the distances plotted are relative to the size of the
object, objects of greatly varying size may be compared to
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one another. This enables the use of ζ as a ranking statistic
where increased ζ implies increased heterogeneity.
Implementation
Computer code to automatically compute ζ on grayscale
images was written in Python v2.6.1 (www.python.org).
Input images consist of an 8-bit grayscale object, where
each object pixel has intensity I > 0, against a uni-
formly black background (I = 0). The images were read
into the program using the Python Imaging Library v1.17
(www.pythonware.com/products/pil/).The xy-coordinate
at each nonzero pixel (an object pixel) along with the
intensity at that pixel was recorded. For every unique
pixel pair, the discrete line between the pair was cal-
culated using Bresenham’s algorithm [13]. Here, we do
not consider the pairs directionally. Thus, once a partic-
ular line from pixel m to pixel n has been considered,
we do not consider again the line from n to m. We
take adjacent pixels to have zero separation and thus
there can be no intensity difference from the gradation
between them. For line endpoints separated by more than
one pixel, the smoothest gradient possible was computed
using Equation 1. For each pixel between the endpoints,
the average absolute difference between the measured
intensity and that given by Equation 1 was computed
via Equation 2. These averages were binned together
for each integer value of the discrete line length. These
binned averages then were themselves averaged, resulting
in a single value at each discrete line length (I). Each
integer line length was divided by the maximum inte-
ger pair-separation observed for the image object. Using
Equation 3, ζ was computed via the trapezoidal rule as
implemented in Numpy v1.4 (www.numpy.org).
Test image database
Images used for numeric tests
Images were obtained as described in Ref. [10]. We briefly
recapitulate the process here. Patients with cancers of the
uterine cervix underwent a pre-treatment hybrid PET/CT
scan using the 18F-fluorodeoxyglucose (FDG) radiotracer
assay of glucose uptake by cells. As is common through-
out the field of nuclear medicine, the raw FDG-PET data
are scatter and attenuation corrected via the proprietary
software native to the PET machine. Images were recon-
structed using ordered subset expectation maximization.
A Gaussian smoothing filter with 4-mm full width at
half maximum was applied post-reconstruction. No addi-
tional processing was implemented. In order to objec-
tively distinguish tumor from background, we employed
the rule-of-thumb that, for a visually selected region of
interest (ROI), any pixel brighter than 40% of the max-
imum ROI pixel brightness is to be considered part of
the tumor [14]. Any remaining objects that are obviously
(for sound anatomical reasons) not tumors are removed
and the final ROI is exported as an 8-bit grayscale region
against a uniformly black background. Here, variations
in grayscale intensity ostensibly imply variations in intra-
tumoral metabolic activity [4]. To quantify these varia-
tions, we apply the computer code earlier described to the
largest cross-sectional tumor image for each patient.
Images used for visual tests
The whole-body images created by our PET scanner are
only 168×168 pixels in size. The segmented tumor region
within these images ranges from only 16 to 291 total pix-
els with a median of 63 pixels. These regions are generally
too small to be inspected visually. Computer code using
the Python Imaging Library (PIL) was used to automati-
cally extract the pre-defined tumor region and paste that
at the center of a new image such that the tumor is cen-
tered within a border which is half of the diameter of the
tumor. This new image was expanded to 162×162 pixels
using the resize function of the PIL with the filter option
set to nearest-neighbor. At 72 dots per inch, this corre-
sponds to squares of side length 2.25 inches. Each image
was printed and then pasted onto a separate piece of stiff
card stock such that a group of images could be readily
seen at once. The expert can then manipulate the cards
into order of increasing image heterogeneity, i.e., visu-
ally evident intensity variations within an isolated tumor
region.
In the rescaled images, very small tumor regions will
appear manifestly “blockier” than very large ones. This
is the typical pixelation seen whenever low-information
images are expanded to greater than the original image
size. The result is that a highly pixelated imagemay appear
innately more homogeneous than a less-pixelated image
simply due the relative sizes of the original pixels in the
rescaled images. Furthermore, the blocky appearance of
the rescaled tumor regions could give a clever physician
some indication of tumor size, even without anatomi-
cal reference. Since we do not want the physicians to
be biased by innate clinical knowledge regarding tumor
size, we binned tumors of similar size into distinct groups
which were independently inspected by the experts.
Comparison of test results
The test image sets earlier described were given to: an
experienced clinical oncologist, a senior medical resident
in the oncology department and a professional image
processing expert with no medical background. Each
expert was asked to rank each image set individually
in order of increasing heterogeneity. Only the experi-
enced oncologist, however, considered tumor shape as
a heterogeneity-defining quality. The other two experts
specifically ignored tumor shape and focused only upon
intra-tumoral pixel variations. The computer code earlier
described was used to compute an objective ranking of
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each image set based solely upon increasing values of the
ζ statistic. The ζ -ranking for each image set was com-
pared to each expert ranking via the Spearman rank test of
statistical correlation. As described in many textbooks, a
p-value associatedwith an upper-tailed test of significance
may be obtained from the Spearman correlation coeffi-
cient. Our null hypothesis is that the computer/expert
rankings are totally uncorrelated. Our alternative hypoth-
esis is that larger ζ values tend to pair with higher
expert-ranked-heterogeneity.
Test of shape dependence
To explore the dependence of ζ upon object shape, we per-
formed the following test. An 8-bit grayscale image of a
circle with radius 16 pixels and origin at the image center
was created. The circle was shaded via a two-dimensional
Gaussian distribution such that the brightest intensity
(255) is at the circle center and the dimmest intensity
(128) occurs at the circle circumference. The result is a
smoothly varying, symmetric “tumor” object. The object
was then decimated by setting all pixels to zero within cir-
cular holes of radius 4 pixels centered at random locations
within the object. As decimation is performed repeatedly
upon the same object, the shape of the object becomes
increasingly irregular. To test the effect of shape upon the
ζ statistic, wemodified the calculation given in Equation 3
to consider contributions from only the nonzero pixels
along the connecting Bresenham lines and replacing the
pair-separation L in Equation 2 with the number of pixels
considered. This way, if the line between a pair of object
pixels crosses the background, the differences of the back-
ground pixels from the smoothest gradation are ignored.
This effectively renders any two background-separated
pixels to be neighbors, thus closing the shape while main-
taining the relative orientation of one endpoint to the
other.
Results and discussion
Because only some oncologists consider shape to con-
tribute to overall tumor heterogeneity, we first describe
the effect of object shape upon ζ . As described in the
Methods section, a smoothly shaded circle was randomly
decimated with circular holes. For a given number of dec-
imations, an ensemble of 36 images was created. Some
typical examples are shown in Figure 2. The ζ statistic was
calculated as given in Equation 3 for each image in the
ensemble and the results averaged to yield a single “shape-
aware” value for a given number of decimations. This
process was then repeated for each ensemble using modi-
fication earlier described to yield a single “shape-unaware”
value, ζu, for a given number of decimations. The result is
shown in Figure 3where the contrast between ζ (triangles)
and ζu (circles) is stark. We note that ζu varies only ≈5%
from the average value and thus shows that ζu is effectively
Figure 2 Repeated randomdecimation of a symmetrically
shaded circle was used to test the shape dependence of the ζ
statistic. Here, typical images of 2, 4, 8 and 16 decimations are
shown. The images shown have been resized for display purposes.
blind to the profound changes in object shape. In contrast,
as the object becomes more irregular in shape, ζ increases
by a factor of two. Additionally, because the greatly dec-
imated objects have much less non-zero object area than
do the slightly decimated objects, the lack of variation in
ζu demonstrates independence from object size.
The ζ statistic was computed for each of the images
shown in Figure 4. Within each image subset (labeled A–
G), the images were ranked automatically in order increas-
ing ζ value. These are the rankings compared to that of
the experts via the Spearman rank test. Table 1 shows the
associated p-values which are the likelihood that a posi-
tive automated/expert rank correlation is due entirely to
chance alone. As indicated by the low p-values in the third
column, the automated rankings via ζ value agree very
well with those given by the veteran oncologist. Such close
agreement is expected to occur by chance in only 1 out of
every 25 attempts. Contrast this to the rankings given by
either the oncology resident or professional image proces-
sor, where similar agreement with the automated ranking
is expected to occur in 1 out of every 5 attempts. It is thus
seen that ζ -ranking agrees very well with those who con-
sider object shape contributions to heterogeneity and does
not agree with those who ignore object shape.
This result was confirmed employing the modified,
shape-unaware calculation described earlier. Our pre-
diction is that ζu will agree with the two experts who
ignored shape in their rankings while disagreeing with the
expert who considered shape to be important. As seen
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Figure 3 The ζ statistic was calculated in shape-aware (triangles)
and shape-unaware (circles) modes. As the object becomes more
irregularly shaped with repeated decimation, the shape-aware
heterogeneity measure increases by a factor of two while the
shape-unaware metric exhibits little variation.
in Table 2, this is precisely what occurred. The expected
chance agreement between the automated and expert
rankings is almost perfectly reversed from those seen
in Table 1.
We further investigated this sensitivity to shape as fol-
lows. Inspection of Figure 4 shows that images D5, D6, E5
and F6 each have the distinctive shape feature of a hole
at the center. For these images of ring-like objects, 29 ≤
ζ ≤ 37. If one scans the entire image set, one finds five
other images with a ζ value in this range. These images—
such as B7, E6 and F5—are clearly not shaped similarly to
the ring-like objects. It is thus seen that although the ring-
like objects differ in ζ value by only 10% of their mean
value, all ζ within this range do not correspond to simi-
lar objects. This demonstrates that while ζ is sensitive to
object shape, it is not slaved to it. That is, one particular
tumor shape does not uniquely correspond to a particu-
lar ζ value. This may be seen concisely in images D4–D6
where ζD4 = ζD5, but have totally different shapes, while
D5 and D6 have very similar shapes but ζ values which
differ by about 10%.
Despite the ordered appearance of the rescaled images
shown in Figure 4, clinically relevant tumor images vary
greatly in size. This may be also seen in Tables 1 and 2
where the range of cross-sectional tumor sizes varies ten-
fold. Since it is the relative arrangement of pixel variations
that ultimately defines heterogeneity, a robust quanti-
fier of heterogeneity should not scale with image size.
For example, doubling the size of a chessboard does not
change the size of the squares, instead, there simply are
more of them. Thus, the heterogeneity is the same for
both sizes of chessboard. With this in mind, we explored
the correlation between ζ and tumor size. Since the ζ
values for the pool of images shown in Figure 4 do not fol-
low a normal distribution, the traditional Pearson product
moment is not applicable. We therefore employ the Spear-
man rank test of correlation and find ρS = 0.044 (p=0.39),
which implies no appreciable correlation between ζ and
object size. This is expected because the effective diameter
of the object (L˜) is divided out of Equation 3.
As mentioned in the Background, there have been
mixed results from previously proposed heterogeneity
metrics. We therefore tested ζ against the measures
shown to be more reproducible and clinically applicable.
Specifically, these metrics are the variance of the intensity
distribution, the local entropy, image energy, image con-
trast and local homogeneity [8-10,12]. The latter fourmet-
rics are calculated from intensity co-occurrence matrices
as described in Ref. [11]. In brief, a co-occurrence matrix
describes the probability that pixels of differing shades
occur as fixed-distance neighbors. As these matrices are
innately directional, we computed the matrices first in the
horizontal (angle=0) and then in the vertical (angle=π/2).
A given heterogeneity metric was then computed from
each matrix and root-mean-square averaged into a sin-
gle measure. In this manner, we computed each of the
proposed metrics on each of our test images. These val-
ues are given in Table 3. Ranking of each image set via
each of the metrics (including ζ ) was done and compared
to those done independently by the veteran oncologist.
As seen in Table 4, ζ -ranking is by far the most consis-
tent with the human expert. In fact, the variance, local
entropy and image energy rankings, on average, do not
agree with expert analysis any better than random chance.
The next best correlation is given by the image contrast
which, on average, clearly did not perform as well as ζ
in ranking our test images consistent with the veteran
oncologist.
Critique of the method
Handling large images
As discussed in earlier sections, while the tumor images
we study vary greatly in size relative to one another,
even the largest tumor yields a fairly small number of
pixel pair combinations. Thus, the isolated tumor objects
are readily processed on a desktop computer. However,
the computational order of ζ is O(L¯N2) where L¯ is
the average distance between two pixels and N is the
number of pixels. Therefore, the exhaustive pairing we
employ on the relatively small tumor regions is unlikely
to be feasible on images containing a large number of
object pixels. For such cases, we suggest that one take
as large a random subset of all possible pixel pairings as
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Figure 4 Tumors of various size, shape, mean intensity and heterogeneity are shown as assayed via FDG-PET. The letter-number at the
top-left indicates the set and ζ -rank within that set. The number at the top-right is the rounded ζ value. The number at the bottom-left is the area of
the tumor given in pixels. The sequence of numbers below is the ranks (within the single set) given to the image by the oncologist, the resident and
the professional, respectively. The images above were rescaled via nearest-neighbor filtering to a convenient display size; thus, the sizes shown
should not be compared directly.
is computationally accessible and proceed to calculate ζ
as before.
Dependence upon bit depth
During computation of ζ , one must take the difference
between a measured intensity and that predicted by the
smoothest gradient. However, the smoothest gradient
possible is determined by the number of shades available
to transition between pixel pairs. Thus, ζ must depend
upon image bit depth. This could be problematic when
comparing image sets from different institutions which
likely employ very different imaging and data storage
protocols. One solution to this is the use of a common
bit depth. For example, in our test images, a threshold
of 40% of the maximum observed intensity was used to
define the tumorous regions. Thus, only the top 60% of
the grayscale range is employed to shade all intra-tumoral
variations. On average, the brightest pixels corresponded
to 80 kBq/mL of radioactivity (data not shown). This
means that only 48 kBq/mL separate the brightest tumor
regions from the dimmest. The noise associated with the
FDG-PET process may be estimated from Ref. [15] to
be∼1 kBq/mL. Thus, only≈48 shades of gray are required
to shade our example objects (the tumors) in such a man-
ner that differing shades correspond to genuinely differing
amounts of radioactivity. A similar downscaling of image
bit depth could be employed on a patient-by-patient basis.
Statistics derived from these images (such as ζ ) could
then be meaningfully compared across patients since
these variations are those common to the physics of the
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Table 1 Automated, shape-aware ranking versus ranking by human experts
Shape aware automated ranking
Shape aware Shape unaware
Set Area (px) Oncologist Resident Professional
A 0–30 0.015 0.020 0.121
B 30–50 0.100 0.025 0.020
C 50–75 0.003 0.185 0.075
D 50–75 0.003 0.220 0.288
E 75–100 0.003 0.375 0.423
F 100-125 0.083 0.250 0.250
G 125–300 0.050 0.250 0.220
Mean 0.04± 0.02 0.19± 0.05 0.20± 0.05
The correlation between the heterogeneity rankings computed via the shape-aware ζ statistic and those done by human experts was quantified via the Spearman
rank test. The p-values given in columns 3–5 are the likelihood that observed correlations are due entirely to random chance. The agreement between the
shape-aware automated ranking and the shape aware expert is outstanding.
imaging modality, not those distinct to an arbitrary choice
of bit depth.
Vectorization of ζ within one image
A directional heterogeneity quantifier is desirable for
cases where the grain of the image has physical mean-
ing. This could occur, for example, for stained histology
slides [16] or for magnetic resonance images of tumors
[17].We suggest that the vectorization of ζ may be accom-
plished as follows. Again, we begin with a pair of arbi-
trarily labeled object pixels at coordinates (xm, ym) and
(xn, yn). Instead of following the Bresenham line directly
from pixel m to pixel n, one first could compute Ix
along a purely horizontal direction—say from (xm, ym) to
(xn, ym)—then compute a purely vertical contributionIy
from (xn, ym) to (xn, yn). We note that
√
(Ix)2 + (Iy)2
Table 2 Automated, shape-unware ranking versus ranking
by human experts
Shape unaware automated ranking
Shape aware Shape unaware
Set Area (px) Oncologist Resident Professional
A 0–30 0.038 0.010 0.038
B 30–50 0.100 0.015 0.020
C 50–75 0.389 0.075 0.050
D 50–75 0.067 0.025 0.010
E 75–100 0.200 0.100 0.021
F 100-125 0.250 0.130 0.083
G 125–300 0.160 0.100 0.123
Mean 0.17± 0.05 0.06± 0.02 0.05± 0.02
Same as Table 1 except that automated ranking via ζu was implemented. As is
seen in columns 4 and 5, the shape-unaware automated rankings agree very
well with the two experts who did not consider shape as contributing to overall
object heterogeneity.
does not equal theI computed directly between (xm, ym)
and (xn, yn), as was described previously. For both Ix
and Iy, the ensemble-averaged, average absolute differ-
ence versus relative length curves may be constructed
and corresponding ζ computed independently for each
direction.
Consider, for example, an image consisting of uniquely
shaded horizontal stripes. The directional ζx = 0 since, for
any pixel m, the intensity at all horizontal distances from
m is identical to that ofm. That same image, however, will
have a ζy > 0 since any vertical line must cross a stripe
boundary at some distance away fromm.
Two important caveats accompany the computation
of directional heterogeneity quantifiers within an image.
First, the choice of moving horizontally then vertically is
completely arbitrary. As one proceeds horizontally from a
given pixel, one encounters different intensity values than
would be encountered had one first proceeded vertically.
This ambiguity also arises when considering the order in
which pixels are paired. Proceeding from the top-left of
the image, the horizontal direction fromm to n is defined
by the upper pixel while pairing from the bottom-right
of the image, it is defined by the lower pixel. Thus, even
decreeing that one always proceeds horizontally first does
not guarantee consistent directional ζ . It is for this rea-
son that we chose to employ a purely scalar ζ ; one which
is unambiguously defined by the pixel pairs. We suggest
that anyone reporting directional ζ also clearly report and
motivate their particular procedural choices.
The second concern lies in the fact that there is no rea-
son to presume that directional components within the
image have physical meaning within the image. There-
fore, what is readily computed as horizontal in the image
data may not be horizontal in the real object. For exam-
ple, there is no guarantee that the stripes of some striped
object align with the vertical or horizontal directions of
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Table 3 The values of the heterogeneitymetrics are given for each of the images shown in Figure 4
Image ζ Variance Entropy Energy Contrast Homogeneity
A1 11.88 1637 3.525 0.03021 5587 0.02554
A2 20.14 2631 3.219 0.04000 4161 0.01220
A3 23.29 2653 3.438 0.03268 5920 0.01479
A4 26.94 2335 3.239 0.03924 6877 0.0009710
A5 27.57 2011 3.395 0.03395 5083 0.002498
A6 28.34 3126 3.332 0.03571 8388 0.01974
A7 29.40 5136 3.044 0.04762 10900 0.004394
B1 11.87 727.8 3.680 0.02561 1866 0.04315
B2 15.97 1369 3.541 0.02964 2249 0.02634
B3 18.10 2478 4.003 0.01862 5839 0.03963
B4 22.15 3415 3.967 0.01906 6252 0.03595
B5 22.73 1357 3.941 0.01974 3030 0.02853
B6 27.64 2609 3.606 0.02742 8517 0.02271
B7 29.56 4110 3.915 0.02018 6469 0.01914
C1 15.70 2411 4.316 0.01383 4240 0.05889
C2 23.44 1393 4.116 0.01688 3575 0.02810
C3 25.61 2940 4.101 0.01708 5516 0.05860
C4 28.07 1854 4.096 0.01685 6124 0.02289
C5 41.14 2393 4.268 0.01440 6347 0.03963
C6 47.69 1874 4.282 0.01425 6941 0.03754
C7 57.55 1322 4.025 0.01881 7908 0.02749
D1 12.05 639.9 4.249 0.01507 782.6 0.08514
D2 15.89 2365 4.051 0.01767 5461 0.03591
D3 28.24 2803 4.235 0.01485 4858 0.03276
D4 28.76 958.3 4.258 0.01513 2991 0.05510
D5 28.87 1387 4.146 0.01698 3901 0.04817
D6 31.85 2747 4.287 0.01396 6006 0.03268
E1 17.50 3465 4.441 0.01206 4293 0.05798
E2 19.12 1094 4.651 0.009870 1830 0.03572
E3 20.16 2698 4.504 0.01131 3811 0.02814
E4 27.76 3783 4.546 0.01073 4879 0.02180
E5 32.66 2707 4.499 0.01146 4118 0.02519
E6 33.30 3524 4.436 0.01196 4720 0.05575
E7 38.46 2236 4.442 0.01224 6014 0.009973
E8 41.48 1795 4.511 0.01226 5278 0.02993
F1 19.60 2615 4.881 0.007653 3129 0.04422
F2 20.81 862.7 4.666 0.009727 3499 0.07422
F3 23.56 2859 4.690 0.009420 3532 0.06246
F4 24.45 1532 4.778 0.008728 2764 0.05223
F5 35.13 1629 4.748 0.009311 4865 0.06013
F6 37.23 1073 4.769 0.008676 3245 0.04870
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Table 3 The values of the heterogeneitymetrics are given for each of the images shown in Figure 4 (continued)
G1 12.63 1360 5.015 0.007085 1227 0.07960
G2 15.50 2900 5.204 0.005643 2442 0.08315
G3 17.37 1481 5.225 0.005581 2086 0.05848
G4 27.16 1993 5.646 0.003828 3253 0.07681
G5 27.83 3818 5.102 0.006177 3372 0.05278
G6 49.00 1172 5.127 0.006370 3836 0.02813
the image. Therefore, before directional quantifiers may
be compared across images, some common reference
frame must be implemented. We suggest that one such
frame is that determined by the quadrupole moment of
the image object. The origin of such a frame is given by
the object dipole. The object may then be translated such
that the dipole is at the center of the image then rotated
such that the strongest quadrupole eigenvector aligns with
(arbitrarily) the x-axis. This way, directional variations
are measured relative to objectively determined reference
frames.
Extension to three dimensions
We present two dimensional (2D) images test images
because we were interested specifically in measuring
correspondence with human experts. Two dimensional
tumor images pasted onto equally-sized cards served as a
ready means of presenting and manipulating the images
into subjective order. Of course, an extension of ζ into
three dimensions (3D) may be desired for a given clin-
ical application. The Bresenham algorithm is extensible
into 3D [18] and is available in many commercial soft-
ware packages currently in common use. Using those 3D
line data, ζ may be computed as described for the 2D
case. A second means of extension into 3D might be as
follows. Instead of drawing the Bresenham line along dis-
crete pixels, a Euclidean line may be drawn directly to
pixel pairs. The intensity value anywhere along that line
may be determined by averaging and/or interpolation of
the neighboring pixels. This gives Im and In in Equation 1.
The absolute intensity difference seen in Equation 2 may
then be averaged along the Euclidean line using arbitrary
intervals. That average may then be used in Equation 3
to compute ζ as was done in the 2D case. While we
expect that a 3D ζ thus computed can be used to objec-
tively rank 3D objects in order of increasing heterogeneity,
the merits of one computational method over another
are not clear and are a subject for further study. Addi-
tionally, if a comparison to expert opinion is to be done
for 3D virtual objects, the rendering technique will also
have to be scrutinized. For example, perception of 3D vir-
tual objects varies greatly from person-to-person. Also,
the construction technique—e.g., brightest intensity ver-
sus average intensity along a given line of sight—adds
variation to the human-computer comparison that likely
requires many repeated trials to overcome. In the present
work, we sought only an introduction to our automated
ranking technique and purposely avoided the complica-
tions involved with extension into three dimensions.
Applications & future work
There is increasing interest in the role of heterogene-
ity within the tumor microenvironment as an indica-
tor of disease prognosis [19]. Therefore, one applica-
tion is to investigate whether the ζ measure has any
prognostic value. Cancer patients where the treatment
Table 4 The correlation between the heterogeneity rankings computed via various statistics and that done
independently by the veteran oncologist was quantifiedvia the Spearman rank test
Ranking statistic
Set Images Area (px) ζ Variance Entropy Energy Contrast Homogeneity
A 7 0–30 0.015 0.305 0.361 0.361 0.164 0.164
B 7 30–50 0.100 0.050 0.333 0.333 0.015 0.305
C 7 50–75 0.003 0.228 0.305 0.389 0.005 0.185
D 6 50–75 0.003 0.250 0.220 0.288 0.190 0.160
E 8 75–100 0.003 0.327 0.481 0.134 0.090 0.167
F 6 100-125 0.083 0.327 0.250 0.220 0.481 0.220
G 6 125–300 0.050 0.288 0.160 0.250 0.083 0.083
Mean 0.04± 0.02 0.25± 0.04 0.30± 0.04 0.28± 0.03 0.15± 0.06 0.18± 0.03
The p-values given in columns 4–9 represent the likelihood that observed correlations are due entirely to random chance.
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response and/or long-term survival is known a priori
could be ranked objectively via ζ heterogeneity. This
could be done for some subset of two-dimensional
images (such as the largest tumor cross-sections) or
for three-dimensional, whole tumor, virtual objects as
described above. The correspondence between hetero-
geneity and disease outcome could then be checked
via rank testing, survival analysis or a Bayesian test of
predictiveness.
Another interesting application of ζ lies in the associa-
tion of a heterogeneity score with intra-tumoral diffusion.
Diffusion tensor imaging (DTI) is a magnetic resonance
modality which can measure the directional diffusion
of water within a cancerous tumor [19,20]. A three
dimensional tumor is imaged via two-dimensional cross
sections. Each image pixel then corresponds to a three-
dimensional vector representing the flow of water at the
coordinate of the pixel. Unlike FDG-PET imaging—where
the relative contributions of intra-cellular metabolism and
inter-cellular density and arrangement are not known—
the images resulting from DTI result directly from
the tumor microenvironment [20]. Thus, anisotropies
in the diffusion imply variations in the initiation and
maintenance of tumor growth. With this in mind, it
would be very interesting to investigate the relation
between the bulk intra-tumoral heterogeneity and dif-
fusion anisotropy. One means of doing this is to parse
the DT images into three sets: one for each vector
component of the diffusion. For inter-patient compar-
isons, these directions could be embedded directions
relative to the tumor itself, for example, the same prin-
cipal eigenvectors from which the fractional anisotropy
is commonly computed [20]. The result is three sets of
three-dimensional coordinates with a grayscale value at
each coordinate which represents the magnitude of dif-
fusion in a given direction at that coordinate. A three-
dimensional ζ may be computed via Equation 3 for
each set of coordinates. Those ζ values, each between
zero and unity, may then be combined to form a single
vector, 	ζ . This 	ζ is very different from the possible
vectorization discussed earlier. There, arbitrary direc-
tions were imposed upon an image to create a vec-
tor quantity within that image. Here, each image set
represents diffusion measured in a distinct physical
direction. Thus, 	ζ is a vector where each compo-
nent measures the heterogeneity of an entire three-
dimensional image set, and that set measures diffusion
in only one physical direction. If one then maps 	ζ
onto an RGB colorspace, the bulk heterogeneity (which
could be indicative of directional diffusion) through-
out the tumor bulk may then be reported as a single
color. For example, it could be the case that tumors
with predominately trans-axial diffusion are less treat-
able than those with predominately planar diffusion.
These differing diffusion scenarios will yield different 	ζ -
colors since two 	ζ of the similar magnitude can still
point in different colorspace directions. The 	ζ -color is
one objective means of quantifying visually perceived
image heterogeneity and relating it to a directional,
physical quantity which itself feasibly relates to tumor
growth. Thus, 	ζ is another means of studying the rela-
tion between image heterogeneity and clinical progno-
sis.
Conclusions
We have demonstrated a method for automatically rank-
ing grayscale medical images in order of increasing het-
erogeneity. We have done this not only in a fashion where
shape is considered to contribute to overall object hetero-
geneity, but also under conditions where shape is ignored.
In both cases, the automatic ranking is found to agree
very well with the rankings done visually by experts.
The example images we analyze, specifically, those of a
grayscale object against a uniformly black background,
are precisely the type of images available after a clini-
cian delineates tumors via standard image segmentation
techniques. For these example cases, our shape-sensitive
ranking statistic was shown to yield heterogeneity rank-
ings which almost perfectly parallel those given by a
veteran radiation oncologist. Automated ranking via het-
erogeneity offers a new avenue for objectively studying the
clinically crucial relation between disease outcome and
some tumor properties observable in the images obtained
at diagnosis.
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Endnotes
aWe note for clarity that the “image energy” and “local
homogeneity” monikers employed by some authors actu-
ally refer to the “angular second moment” and “inverse
difference moment”, respectively, as originally given in
Ref. [11].
bWe note again that this is the trans-axial direc-
tion relative to the tumor—as determined by the three-
dimensional principal components of the image set—
which is not necessarily the trans-axial direction of the
clinical imaging process.
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